Follitropin alpha

DRUG3 trials

Sponsors

Merck KGaA, Darmstadt, Germany, Azienda USL Modena, Lund University

Conditions

AnovulationFemale InfertilityHypothalamic-pituitary DysfunctionMale InfertilityOligo-ovulationPolycystic Ovarian Syndrome

Phase 2

FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy

CompletedNCT02349945

Azienda USL ModenaMale Infertility

Start: 2011-01-31End: 2015-12-31Updated: 2016-07-12

Phase 3

Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women

CompletedNCT01653743

Merck KGaA, Darmstadt, GermanyAnovulation, Hypothalamic-pituitary Dysfunction, Oligo-ovulation +1

Start: 2012-09-30End: 2014-12-31Updated: 2016-01-07

Unknown Phase

Hormone Evaluation in Artificial Reproductive Technology

CompletedNCT03737253

Lund UniversityFemale Infertility

Start: 2016-09-30End: 2024-10-02Updated: 2025-03-17